TY - JOUR AU - Gesi, M. AU - Soldani, P. AU - Giorgi, F. S. PY - 2000 DA - 2000// TI - The role of the locus coeruleus in the development of Parkinson's disease JO - Neurosci Biobehav Rev VL - 24 UR - https://doi.org/10.1016/S0149-7634(00)00028-2 DO - 10.1016/S0149-7634(00)00028-2 ID - Gesi2000 ER - TY - CHAP AU - Agid, Y. AU - Javoy-Agid, F. AU - Ruberg, M. ED - Marsden, C. D. ED - Fahn, S. PY - 1987 DA - 1987// TI - Biochemistry of neurotransmitters in Parkinson's disease BT - Movement Disorders 2 PB - Butterworths CY - New York ID - Agid1987 ER - TY - JOUR AU - Hurst, J. H. AU - LeWitt, P. A. AU - Burns, R. S. AU - Foster, N. L. AU - Lovenberg, W. PY - 1985 DA - 1985// TI - CSF dopamine β-hydroxylase activity in Parkinson's disease JO - Neurology VL - 35 UR - https://doi.org/10.1212/WNL.35.4.565 DO - 10.1212/WNL.35.4.565 ID - Hurst1985 ER - TY - JOUR AU - Chan-Palay, V. AU - Asan, A. PY - 1989 DA - 1989// TI - Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression JO - J Comp Neurol VL - 287 UR - https://doi.org/10.1002/cne.902870308 DO - 10.1002/cne.902870308 ID - Chan-Palay1989 ER - TY - JOUR AU - Benarroch, E. E. PY - 2009 DA - 2009// TI - The locus coeruleus norepinephrine system: functional organization and potential clinical significance JO - Neurology VL - 73 UR - https://doi.org/10.1212/WNL.0b013e3181c2937c DO - 10.1212/WNL.0b013e3181c2937c ID - Benarroch2009 ER - TY - JOUR AU - Greenfield, J. G. AU - Bosanquet, F. D. PY - 1953 DA - 1953// TI - The brainstem lesions in Parkinsonism JO - J Neurol Neurosurg Psychiatry VL - 16 UR - https://doi.org/10.1136/jnnp.16.4.213 DO - 10.1136/jnnp.16.4.213 ID - Greenfield1953 ER - TY - JOUR AU - Del Tredici, K. AU - Rüb, U. AU - De Vos, R. A. AU - Bohl, J. R. AU - Braak, H. PY - 2002 DA - 2002// TI - Where does Parkinson disease pathology begin in the brain? JO - J Neuropathol Exp Neurol VL - 61 ID - Del Tredici2002 ER - TY - JOUR AU - Götz, M. E. AU - Künig, G. AU - Riederer, P. AU - Youdim, M. B. PY - 1994 DA - 1994// TI - Oxidative stress: free radical production in neural degeneration JO - Pharmacol Ther VL - 63 UR - https://doi.org/10.1016/0163-7258(94)90055-8 DO - 10.1016/0163-7258(94)90055-8 ID - Götz1994 ER - TY - JOUR AU - Hirsch, E. C. AU - Hunot, S. PY - 2009 DA - 2009// TI - Neuroinflammation in Parkinson's disease: a target for neuroprotection? JO - Lancet Neurol VL - 8 UR - https://doi.org/10.1016/S1474-4422(09)70062-6 DO - 10.1016/S1474-4422(09)70062-6 ID - Hirsch2009 ER - TY - JOUR AU - Rommelfanger, K. S. AU - Weinshenker, D. PY - 2007 DA - 2007// TI - Norepinephrine: the redheaded stepchild of Parkinson's disease JO - Biochem Pharmacol VL - 74 UR - https://doi.org/10.1016/j.bcp.2007.01.036 DO - 10.1016/j.bcp.2007.01.036 ID - Rommelfanger2007 ER - TY - JOUR AU - Mavridis, M. AU - Colpaert, F. C. AU - Millan, M. J. PY - 1991 DA - 1991// TI - Differential modulation of (+)- amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha-1 as compared to alpha 2 agonists and antagonists JO - Brain Res VL - 562 UR - https://doi.org/10.1016/0006-8993(91)90624-5 DO - 10.1016/0006-8993(91)90624-5 ID - Mavridis1991 ER - TY - JOUR AU - Marien, M. AU - Briley, M. AU - Coplaert, F. PY - 1993 DA - 1993// TI - Noradrenaline exacerbates MPTP-induced striatal dopamine loss in mice JO - Eur J Pharmacol VL - 236 UR - https://doi.org/10.1016/0014-2999(93)90489-5 DO - 10.1016/0014-2999(93)90489-5 ID - Marien1993 ER - TY - JOUR AU - Fornai, F. AU - Bassi, L. AU - Torracca, M. T. AU - Scalori, V. AU - Corsini, G. U. PY - 1995 DA - 1995// TI - Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice JO - Eur J Pharmacol VL - 283 UR - https://doi.org/10.1016/0014-2999(95)00313-A DO - 10.1016/0014-2999(95)00313-A ID - Fornai1995 ER - TY - JOUR AU - Kilbourn, M. R. AU - Sherman, P. AU - Abbott, L. C. PY - 1998 DA - 1998// TI - Reduced MPTP toxicity in striatum of the mutant mouse tottering JO - Synapse VL - 30 UR - https://doi.org/3.0.CO;2-0 DO - 3.0.CO;2-0 ID - Kilbourn1998 ER - TY - JOUR AU - Grenhoff, J. AU - Nisell, M. AU - Ferre, S. PY - 1993 DA - 1993// TI - Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat JO - J Neural Transm Gen Sect VL - 93 UR - https://doi.org/10.1007/BF01244934 DO - 10.1007/BF01244934 ID - Grenhoff1993 ER - TY - JOUR AU - Foster, N. L. AU - Newman, R. P. AU - LeWitt, P. A. PY - 1984 DA - 1984// TI - Peripheral beta-adrenergic blockade treatment of Parkinsonian tremor JO - Ann Neurol VL - 16 UR - https://doi.org/10.1002/ana.410160412 DO - 10.1002/ana.410160412 ID - Foster1984 ER - TY - JOUR AU - Carpentier, A. F. AU - Bonnet, A. M. AU - Vidhailhet, M. AU - Agid, Y. PY - 1996 DA - 1996// TI - Improvement of levodopainduced dyskinesia by propranolol in Parkinson's disease JO - Neurology VL - 46 UR - https://doi.org/10.1212/WNL.46.6.1548 DO - 10.1212/WNL.46.6.1548 ID - Carpentier1996 ER - TY - JOUR AU - Rascol, O. AU - Arnulf, I. AU - Peyro-Saint Paul, H. PY - 2001 DA - 2001// TI - Idoxozan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease JO - Clin Neuropharmacol VL - 16 ID - Rascol2001 ER - TY - CHAP AU - LeWitt, P. A. AU - Hauser, R. A. AU - Lu, M. PY - 2011 DA - 2011// TI - Fipamezole in the treatment of dyskinesias in advanced Parkinson disease (FJORD study) BT - Neurology ID - LeWitt2011 ER - TY - JOUR AU - Mathias, C. J. PY - 2008 DA - 2008// TI - L-dihydroxyphenylserine (droxidopa) in the treatment of orthostatic hypotension: the European experience JO - Clin Auton Res VL - 18 UR - https://doi.org/10.1007/s10286-007-1005-z DO - 10.1007/s10286-007-1005-z ID - Mathias2008 ER - TY - JOUR AU - Narabayashi, H. AU - Nakanishi, T. AU - Kanazawa, I. PY - 1987 DA - 1987// TI - Clinical effects of L-threo-3,4-dihydroxyphenylserine in Parkinson's disease and Parkinson syndrome: results of multi-center open study at 45 institutions JO - Yakuri To Chiryo [Japan Pharmacol Ther; in Japanese] VL - 15 ID - Narabayashi1987 ER - TY - JOUR AU - Bédard, M. A. AU - el Massioui, F. AU - Malapani, C. PY - 1998 DA - 1998// TI - Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist JO - Clin Neuropharm VL - 21 ID - Bédard1998 ER - TY - JOUR AU - Riekkinen, M. AU - Jäkälä, P. AU - Kejonen, K. AU - Riekkinen, P. PY - 1999 DA - 1999// TI - The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease JO - Neuroscience VL - 92 UR - https://doi.org/10.1016/S0306-4522(99)00037-8 DO - 10.1016/S0306-4522(99)00037-8 ID - Riekkinen1999 ER - TY - JOUR AU - Marsh, L. AU - Biglan, K. AU - Gerstenhaber, M. AU - Williams, J. R. PY - 2009 DA - 2009// TI - Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study JO - Mov Disord VL - 24 UR - https://doi.org/10.1002/mds.22307 DO - 10.1002/mds.22307 ID - Marsh2009 ER - TY - JOUR AU - Dubois, B. AU - Pillon, B. PY - 1997 DA - 1997// TI - Cognitive deficits in Parkinson's disease JO - J Neurol VL - 244 UR - https://doi.org/10.1007/PL00007725 DO - 10.1007/PL00007725 ID - Dubois1997 ER - TY - JOUR AU - Remy, P. AU - Doder, M. AU - Lees, A. AU - Turjanski, N. AU - Brooks, D. PY - 2005 DA - 2005// TI - Depression in Parkinson's disease: loss of dopamine and noradrenaline innervations in the limbic system JO - Brain VL - 128 UR - https://doi.org/10.1093/brain/awh445 DO - 10.1093/brain/awh445 ID - Remy2005 ER - TY - JOUR AU - Pintor, L. AU - Baillès, E. AU - Valldeoriola, F. PY - 2006 DA - 2006// TI - Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode JO - Gen Hosp Psychiatry VL - 28 UR - https://doi.org/10.1016/j.genhosppsych.2005.07.005 DO - 10.1016/j.genhosppsych.2005.07.005 ID - Pintor2006 ER -